Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Kim, 2006, Lymphatic mapping and sentinel lymph node biopsy in early stage breast carcinoma: a metaanalysis, Cancer, 106, 4, 10.1002/cncr.21568

Haid, 2002, Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer, Eur J Surg Oncol, 28, 705, 10.1053/ejso.2002.1327

Helms, 2009, Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection: data from a prospective randomised trial, Eur J Surg Oncol, 35, 697, 10.1016/j.ejso.2008.06.013

Kaufmann, 2007, Recommendation from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives, 2006, Ann Oncol, 18, 1927, 10.1093/annonc/mdm201

Fisher, 1997, Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18, J Clin Oncol, 15, 2483, 10.1200/JCO.1997.15.7.2483

Kuerer, 1999, Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy, Ann Surg, 230, 72, 10.1097/00000658-199907000-00011

Krag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 phase III trial, Lancet Oncol, 8, 881, 10.1016/S1470-2045(07)70278-4

Krag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016/S1470-2045(10)70207-2

Rouzier, 2002, Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes, J Clin Oncol, 20, 1304, 10.1200/JCO.20.5.1304

Smith, 2012, Using chemotherapy response to personalise choices regarding locoregional therapy: a new era in breast cancer treatment?, J Clin Oncol, 30, 3913, 10.1200/JCO.2012.44.4539

Xing, 2006, Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer, Br J Surg, 93, 539, 10.1002/bjs.5209

Kelly, 2009, Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy: systematic review and meta analysis, Acad Radiol, 16, 551, 10.1016/j.acra.2009.01.026

Van Deurzen, 2009, Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review, Eur J Cancer, 45, 3124, 10.1016/j.ejca.2009.08.001

Lee, 2007, Sentinel node identification rate, but not accuracy, is significantly decreased after preoperative chemotherapy in axillary node-positive patients, Breast Cancer Res Treat, 102, 283, 10.1007/s10549-006-9330-9

Newman, 2007, Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation, Ann Surg Oncol, 14, 2946, 10.1245/s10434-007-9403-y

Le Bouëdec, 2006, Sentinel lymph node biopsy for breast cancer after neoadjuvant chemotherapy: influence of nodal status before treatment, Bull Cancer, 93, 415

Shen, 2007, Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases, Cancer, 109, 1255, 10.1002/cncr.22540

Takahashi, 2012, Correlation between clinical nodal status and sentinel lymph node biopsy false negative rate after neoadjuvant chemotherapy, World J Surg, 36, 2847, 10.1007/s00268-012-1704-z

Alvarado, 2012, The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer, Ann Surg Oncol, 19, 3177, 10.1245/s10434-012-2484-2

Classe, 2009, Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study, J Clin Oncol, 27, 726, 10.1200/JCO.2008.18.3228

Khan, 2005, Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy, Ann Surg Oncol, 12, 697, 10.1245/ASO.2005.09.007

Kuehn, 2005, A concept for the clinical implementation of sentinel lymph node biopsy (SLNB) in breast cancer patients with special regard to quality assurance, Cancer, 103, 451, 10.1002/cncr.20786

Lyman, 2005, American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer, J Clin Oncol, 23, 7703, 10.1200/JCO.2005.08.001

Sobin, 2009

Kuehn, 2004, Sentinel-node-biopsy is a reliable method for axillary staging in breast cancer: results from a large prospective German multi-institutional trial, Eur J Surg Oncol, 30, 252, 10.1016/j.ejso.2003.11.016

Boughey, 2012, The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 trial, Cancer Res, 72

Mamounas, 2005, Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from NSABP protocol B-27, J Clin Oncol, 23, 2694, 10.1200/JCO.2005.05.188

Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases, Ann Surg, 252, 426, 10.1097/SLA.0b013e3181f08f32